Health Products Act 2007 · 2020 Revised Edition · Part 8 · Duties of Manufacturers, Importers, Etc., of Health Products
42. Reporting of defects and adverse effects to Authority
Feedback & supportWhere the manufacturer, importer, supplier or registrant of a health product becomes aware of —
registrant
“registrant”, in relation to a registered health product, means the person who applied for and obtained the registration of the health product under this Act;
any defect in the health product; or
any adverse effect that has arisen or can arise from the use of the health product,it is the duty of such person to inform the Authority within the prescribed time of the defect or adverse effect.
Where the Authority receives any information under subsection (1) concerning any defect in, or adverse effect of, a health product or becomes aware of any such defect or adverse effect through any other means, it may take any one or more of the following actions:
by written notice require the manufacturer, importer, supplier or registrant of the health product to investigate into the defect or adverse effect and make a report of the findings and recommendations to the Authority;
by written notice require the manufacturer, importer, supplier or registrant of the health product to issue or cause to be issued to such persons as the Authority may specify or to the general public a statement informing them of the defect or adverse effect and the measures that should be taken for addressing the defect or adverse effect;
by written notice require the manufacturer, importer, supplier or registrant of the health product to recall the health product and take such measures as the Authority may specify to secure the immediate stoppage of the manufacture, import, supply, use or administration (as the case may be) of the health product;
by written notice prohibit any person from using or administering the health product and require the person to take such measures as the Authority may specify to address any adverse effect that may have arisen from any previous use or administration of the health product;
by written notice require the manufacturer, importer, supplier or registrant of the health product to take any other measures as the Authority thinks necessary in the circumstances.
The Authority may also in any written notice given under subsection (2) require the person to whom the notice has been given to submit to the Authority in such form and manner and within such time and for such period specified by the Authority, a report containing information on —
the measures that the person has taken under the notice;
the results of the measures so taken; and
any other matter as the Authority thinks necessary or relevant in the circumstances.
A statement under subsection (2)(b) must be issued in such form and manner as the Authority may require, including —
by publication in any one or more daily newspapers circulating in Singapore; or
by dissemination in any alternative medium,within the time and for the period as the Authority may determine.
Any person who —
fails to comply with subsection (1) or a notice given to the person by the Authority under subsection (2) or (3); or
in compliance or purported compliance with subsection (1) or a notice given to the person by the Authority under subsection (2) or (3), furnishes the Authority with any information or document which the person knows is false or misleading,shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $20,000 or to imprisonment for a term not exceeding 12 months or to both.
For the purposes of this section, a health product has a defect if —
health product
“health product” means any substance, preparation or device —(a)that —(i)is represented for use by humans;(ii)whether because of its presentation or otherwise, is likely to be taken for use by humans; or(iii)is included in a class of substances, preparations or devices which are or are ordinarily intended for use by humans,solely or principally for a health-related purpose; and(b)that falls within any of the categories of health products specified in the First Schedule;
it has or has possibly been adulterated or tampered with;
it is or is possibly a counterfeit or an unwholesome health product;
it is or is possibly of inadequate quality or unsafe or inefficacious for its intended purpose; or
it fails or could possibly fail to satisfy such other standards or requirements as may be prescribed.